Inactive Instrument
Aradigm Corporation Stock Nasdaq
Stocks
US0385054004
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 4.89M 4.24M 3.97M 3.63M 6.86M 465M 6.94M 46.44M 18.23M 233M 18.34M 17.94M 774M | P/E 2016 |
-0.72x | P/E 2017 | -9.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.8M 11.11M 10.4M 9.51M 17.96M 1.22B 18.19M 122M 47.75M 609M 48.05M 47.01M 2.03B | EV / Sales 2016 |
73.3x | EV / Sales 2017 | 7.27x |
| Free-Float |
60.28% | Yield 2016 * |
-
| Yield 2017 | - |
| 1 day | +36.88% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +36.88% | +25.50% | - | - | 702K | |
| +0.93% | -0.63% | +3.89% | +15.59% | 48.57B | |
| -0.27% | +2.73% | +438.38% | +566.08% | 41.95B | |
| -2.95% | -3.44% | +29.36% | +4.70% | 38.85B | |
| -0.25% | +1.43% | +9.43% | +74.21% | 37.24B | |
| +2.47% | +8.33% | +15.16% | +48.37% | 30.67B | |
| -1.71% | +0.11% | +34.52% | +122.33% | 16.41B | |
| +1.84% | -0.70% | - | - | 16.1B | |
| +0.29% | +1.87% | +8.17% | +19.01% | 13.97B | |
| -2.13% | -3.00% | +3.31% | -36.17% | 12.62B | |
| Average | +3.48% | -0.30% | +67.78% | +101.76% | 28.48B | |
| Weighted average by Cap. | -0.19% | +0.39% | +88.47% | +127.97% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 195K 169K 158K 145K 274K 18.58M 277K 1.85M 728K 9.28M 732K 716K 30.89M | 14.46M 12.55M 11.75M 10.75M 20.3M 1.38B 20.56M 138M 53.97M 688M 54.31M 53.13M 2.29B |
| Net income | -32.94M -28.58M -26.77M -24.48M -46.22M -3.14B -46.82M -313M -123M -1.57B -124M -121M -5.22B | -10.7M -9.29M -8.7M -7.96M -15.02M -1.02B -15.22M -102M -39.94M -509M -40.19M -39.32M -1.7B |
| Net Debt | -9.37M -8.13M -7.62M -6.97M -13.15M -893M -13.32M -89.09M -34.97M -446M -35.19M -34.42M -1.48B | 7.91M 6.87M 6.43M 5.88M 11.1M 754M 11.25M 75.22M 29.52M 377M 29.71M 29.06M 1.25B |
Employees
-
